Redcliffe's team focusing on the pharma sector combines an outstanding legal and transactional track record with an in-depth understanding of industry developments.

Our team represents many industry heavyweights, including Abbott Laboratories, Liorco Investments (which owns significant pharmaceutical business assets in Ukraine), and other significant players. Our work in this sector involves the full of issues, including:

  • Regulatory reviews, advice and compliance
  • M&A transactions and joint ventures
  • Protecting patents and other IP assets
  • Antitrust and unfair competition
  • Advertising law
  • Implementing immediate actions in the case of product recalls and product liability cases
  • Dispute resolution

Redcliffe's team has a track record of working with the world's leading and emerging pharmaceutical, chemicals, medical device and health care services companies, providing:

  • Access to our combined knowledge, expertise and experience in the sector
  • Lawyers who know the risks and challenges within the industry and who proactively bring insights to clients